Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,267
Employees75,267
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,267
Employees75,267

NVS Key Statistics

Market cap
358.31B
Market cap358.31B
Price-Earnings ratio
22.83
Price-Earnings ratio22.83
Dividend yield
1.98%
Dividend yield1.98%
Average volume
2.62M
Average volume2.62M
High today
$170.46
High today$170.46
Low today
$167.61
Low today$167.61
Open price
$169.17
Open price$169.17
Volume
3.08M
Volume3.08M
52 Week high
$170.46
52 Week high$170.46
52 Week low
$97.72
52 Week low$97.72

NVS News

TipRanks 2h
Trump says ‘tariffs have influenced’ Novartis to build 7+ facilities

President Donald Trump stated in a post to Truth Social: “Tariffs have influenced Novartis (NVS), and its great leader, Vasant (Vas) Narasimhan, M.D., to build...

TipRanks 7h
Novartis completes acquisition of Avidity Biosciences

Novartis (NVS) announced that it has successfully completed its acquisition of Avidity Biosciences (RNA). With the completion of the acquisition, Avidity is now...

TipRanks 9h
Novartis receives positive CHMP opinion for remibrutinib in CSU

Novartis (NVS) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has adopted a positive opinion re...

Analyst ratings

45%

of 29 ratings
Buy
37.9%
Hold
44.8%
Sell
17.2%

More NVS News

TipRanks 22h
Avidity Shareholders Approve Novartis Merger and Spin-Off

Avidity Biosciences ( (RNA) ) has provided an announcement. At a special meeting held virtually on February 26, 2026, Avidity Biosciences stockholders approved...

TipRanks 2d
Novartis to build radioligand therapy site in Denton, Texas

Novartis (NVS) announced plans to establish a new 46,000-square-foot radioligand therapy manufacturing site in Denton, Texas. This purpose-built RLT site will b...

The Motley Fool 3d
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?

It has the qualities of a buy-and-forget stock. Many people aim to save at least $1 million for their retirement years to help supplement programs like Social...

Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
Nasdaq 3d
Novartis: Pluvicto Shows Effectiveness In Real-world Studies

(RTTNews) - Novartis (NVS) said multiple US real-world studies reinforced earlier use of Pluvicto before chemotherapy in metastatic castration-resistant prostat...

Novartis: Pluvicto Shows Effectiveness In Real-world Studies
TipRanks 4d
Avidity Biosciences Advances Toward Novartis Merger Completion

Avidity Biosciences ( (RNA) ) has shared an announcement. On February 23, 2026, Avidity Biosciences, Inc. announced that it would open its special meeting of s...

Nasdaq 5d
Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades

Key Points Novartis is a large drugmaker with a wide-ranging portfolio. Like all drugmakers, it faces the challenge of patent expirations. Still, the company...

Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.